LISBON — Patients with acute heart failure on the sodium-glucose cotransporter 2 (SGLT2) inhibitor dapagliflozin who received diuretic therapy experienced rapid decongestion with shorter hospital stays,...
STOCKHOLM — In the treatment of type 2 diabetes, sodium-glucose cotransporter 2 (SGLT2) inhibitors and glucagon-like peptide 1 receptor agonists (GLP-1 RAs) show independent benefits that...